Index Entries

"557 HCQ COVID-19 studies, 433 peer reviewed, 413 comparing treatment and control groups. Late treatment and high dosages may be harmful, while early treatment consistently shows positive results. Negative evaluations typically ignore treatment delay. Some In Vitro evidence suggested therapeutic levels would not be reached, however that was incorrect."

website
COVID-19,hydroxychloroquine,medical treatments,pharmaceuticals